William Brady

8.2k total citations · 5 hit papers
28 papers, 7.0k citations indexed

About

William Brady is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, William Brady has authored 28 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 8 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Oncology. Recurrent topics in William Brady's work include T-cell and B-cell Immunology (13 papers), Immune Cell Function and Interaction (8 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). William Brady is often cited by papers focused on T-cell and B-cell Immunology (13 papers), Immune Cell Function and Interaction (8 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). William Brady collaborates with scholars based in United States, Germany and Denmark. William Brady's co-authors include Peter S. Linsley, J A Ledbetter, Laura S. Grosmaire, Nitin K. Damle, P S Linsley, J A Ledbetter, Jürgen Bajorath, Robert Peach, Alejandro Aruffo and Jeffrey A. Bluestone and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

William Brady

28 papers receiving 6.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CTLA-4 is a second receptor for the B cell activation antigen B7.

1991 1.4k citations Peter S. Linsley, William Brady et al. The Journal of Experimental Medicine profile →
Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation.

1991 1.0k citations P S Linsley, William Brady et al. The Journal of Experimental Medicine profile →
Long-Term Survival of Xenogeneic Pancreatic Islet Grafts Induced by CTLA4lg

1992 966 citations William Brady, Peter S. Linsley et al. profile →
Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4

1992 912 citations Lieping Chen, William Brady et al. Cell profile →
Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors

1994 786 citations P S Linsley, William Brady et al. Immunity profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
William Brady	5.4k	1.8k	985	873	723	28	7.0k
John Iacomini	3.8k 0.7×	1.0k 0.6×	2.0k 2.0×	1.0k 1.2×	264 0.4×	84	6.8k
Joanna R. Groom	5.5k 1.0×	1.5k 0.9×	1.0k 1.0×	601 0.7×	511 0.7×	63	7.5k
Michael P. Cancro	6.5k 1.2×	665 0.4×	1.2k 1.3×	668 0.8×	881 1.2×	143	8.4k
Thomas Hünig	4.3k 0.8×	1.1k 0.6×	1.1k 1.1×	385 0.4×	546 0.8×	137	5.9k
H. Festenstein	3.2k 0.6×	507 0.3×	815 0.8×	974 1.1×	894 1.2×	193	5.0k
Jonathan C. Poe	4.2k 0.8×	855 0.5×	917 0.9×	318 0.4×	1.1k 1.6×	62	5.8k
Marcel Batten	3.8k 0.7×	1.1k 0.6×	712 0.7×	601 0.7×	425 0.6×	40	5.5k
Rachel Ettinger	4.3k 0.8×	831 0.5×	1.4k 1.4×	403 0.5×	412 0.6×	53	5.9k
Flavius Martin	4.8k 0.9×	582 0.3×	1.1k 1.1×	478 0.5×	1.1k 1.5×	39	6.5k
Jacques F.A.P. Miller	5.8k 1.1×	1.4k 0.8×	1.1k 1.1×	728 0.8×	347 0.5×	61	6.8k

Countries citing papers authored by William Brady

Since Specialization

Citations

This map shows the geographic impact of William Brady's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Brady with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Brady more than expected).

Fields of papers citing papers by William Brady

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Brady. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Brady. The network helps show where William Brady may publish in the future.

Co-authorship network of co-authors of William Brady

This figure shows the co-authorship network connecting the top 25 collaborators of William Brady. A scholar is included among the top collaborators of William Brady based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William Brady. William Brady is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stenderup, Karin, Cecilia Rosada, Kurt Shanebeck, et al.. (2015). AZ17: a new bispecific drug targeting IL-6 and IL-23 with potential clinical use—improves psoriasis in a human xenograft transplantation model. Protein Engineering Design and Selection. 28(10). 467–480. 14 indexed citations

Wang, Eunice S., Gerald J. Fetterly, William Brady, et al.. (2013). Clinical and Biologic Effects Of The Angiopoietin 1/2 Neutralizing Peptibody, Trebananib (AMG 386), In Acute Myeloid Leukemia Patients. Blood. 122(21). 2701–2701. 5 indexed citations

Nickerson‐Nutter, Cheryl, Lioudmila Tchistiakova, Nilufer P. Seth, et al.. (2011). Distinct in vitro binding properties of the anti-CD20 small modular immunopharmaceutical 2LM20-4 result in profound and sustained in vivo potency in cynomolgus monkeys. Lara D. Veeken. 50(6). 1033–1044. 6 indexed citations

Jain, Ashish, Chi A., Eduardo López‐Granados, et al.. (2004). Specific NEMO mutations impair CD40-mediated c-Rel activation and B cell terminal differentiation. Journal of Clinical Investigation. 114(11). 1593–1602. 67 indexed citations

Aicher, Alexandra, Martha Hayden-Ledbetter, William Brady, et al.. (2000). Characterization of Human Inducible Costimulator Ligand Expression and Function. The Journal of Immunology. 164(9). 4689–4696. 205 indexed citations

Brady, William, et al.. (1996). Cloning, Characterization, and Modeling of Mouse and Human Guanylate Kinases. Journal of Biological Chemistry. 271(28). 16734–16740. 40 indexed citations

Linsley, Peter S., Steven G. Nadler, Jürgen Bajorath, et al.. (1995). Binding Stoichiometry of the Cytotoxic T Lymphocyte-associated Molecule-4 (CTLA-4). Journal of Biological Chemistry. 270(25). 15417–15424. 90 indexed citations

Peach, Robert, Jürgen Bajorath, William Brady, et al.. (1994). Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1.. The Journal of Experimental Medicine. 180(6). 2049–2058. 201 indexed citations

Linsley, P S, et al.. (1994). Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity. 1(9). 793–801. 786 indexed citations breakdown →

10.

Sciammas, Roger, Raymond M. Johnson, Anne I. Sperling, et al.. (1994). Unique antigen recognition by a herpesvirus-specific TCR-gamma delta cell.. The Journal of Immunology. 152(11). 5392–5397. 142 indexed citations

11.

Linsley, Peter S., Margit Gayle, Jürgen Bajorath, et al.. (1994). Single-chain mono- and bispecific antibody derivatives with novel biological properties and antitumour activity from a COS cell transient expression system.. PubMed. 1(1). 3–15. 43 indexed citations

12.

Dietrich, Andrea, R Niedner, Alexander Kapp, et al.. (1993). Phorbol-12-Myristate-13-Acetate-Treated Human Keratinocytes Express B7-Like Molecules That Serve a Costimulatory Role in T-Cell Activation. Journal of Investigative Dermatology. 100(3). 275–281. 39 indexed citations

13.

Nelson, Andrew, Suzanne Hosier, William Brady, Peter S. Linsley, & Andrew G. Farr. (1993). Medullary thymic epithelium expresses a ligand for CTLA4 in situ and in vitro.. The Journal of Immunology. 151(5). 2453–2461. 60 indexed citations

14.

Chen, Lieping, William Brady, Karl Erik Hellström, et al.. (1992). Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell. 71(7). 1093–1102. 912 indexed citations breakdown →

15.

Liu, Yang, et al.. (1992). Co‐stimulation of murine CD4 T cell growth: cooperation between B7 and heat‐stable antigen. European Journal of Immunology. 22(11). 2855–2859. 126 indexed citations

16.

Linsley, P S, William Brady, Laura S. Grosmaire, et al.. (1991). Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation.. The Journal of Experimental Medicine. 173(3). 721–730. 1003 indexed citations breakdown →

17.

Linsley, Peter S., et al.. (1991). CTLA-4 is a second receptor for the B cell activation antigen B7.. The Journal of Experimental Medicine. 174(3). 561–569. 1423 indexed citations breakdown →

18.

Storb, U, Carl A. Pinkert, B Arp, et al.. (1986). Transgenic mice with mu and kappa genes encoding antiphosphorylcholine antibodies.. The Journal of Experimental Medicine. 164(2). 627–641. 120 indexed citations

19.

Sommers, Ronald K., et al.. (1976). Performances of Articulatory Defective, Minimal Brain Dysfunctioning, and Normal Children on Dichotic Ear Preference, Laterality, and Fine-Motor Skills Tasks. The Journal of Special Education. 10(1). 5–14. 7 indexed citations

20.

Sommers, Ronald K., William Brady, & W.H. Moore. (1975). Dichotic Ear Preferences of Stuttering Children and Adults. Perceptual and Motor Skills. 41(3). 931–938. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact